← FDA DRUG APPROVALS

FDA ANDA · ANDA073316

ATENOLOL

Sponsor: TEVA

APPLICATION
ANDA073316
TYPE
ANDA
ORIGINAL APPROVAL
1993-05-28
LATEST ACTION
2000-02-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATENOLOLDiscontinued
ATENOLOL 100MG · TABLET · ORAL

Approval history

2000-02-16Labeling · Supplement 7AP
1998-05-13Manufacturing (CMC) · Supplement 5AP
1996-11-01Labeling · Supplement 4AP
1995-05-30Manufacturing (CMC) · Supplement 3AP
1994-12-30Labeling · Supplement 2AP
1993-09-08Labeling · Supplement 1AP
1993-05-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →